Insider Trading & Ownership - Edwards Martin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Edwards Martin
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2024-08-16
Sale		 2024-08-21
4:36 pm		 Morphic Holding Inc. MORF Edwards Martin
Director		 2,376 $0 $0 0
(Direct)		 View
2023-11-20
Purchase		 2023-11-22
5:09 pm		 Verona Pharma plc VRNA Edwards Martin
Director		 33,736 $1.837 $61,973 144,800
(Direct)		 View
2023-11-13
Purchase		 2023-11-15
7:00 pm		 Morphic Holding Inc. MORF Edwards Martin
Director		 2,376 $20.54 $48,803 2,376
(Direct)		 View
2023-09-26
Sale		 2023-09-26
4:30 pm		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 6,116 $0 $0 0
(Direct)		 View
2021-05-04
Sale		 2021-05-05
5:04 pm		 Verona Pharma plc VRNA Edwards Martin
Director		 12,024 $0.8397 $10,097 111,064
(Direct)		 View
2021-02-01
Sale		 2021-02-03
7:09 pm		 Verona Pharma plc VRNA Edwards Martin
Director		 13,688 $0.9938 $13,603 123,088
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-06-18
Option Award		 2024-06-20
4:07 pm		 N/A
2034-06-17		 Inozyme Pharma Inc. INZY Edwards Martin
Director		 28,000 $0 28,000
(Direct)		 View
2024-06-04
Option Award		 2024-06-05
8:21 pm		 N/A
2034-06-03		 Morphic Holding Inc. MORF Edwards Martin
Director		 23,168 $0 23,168
(Direct)		 View
2024-04-29
Option Award		 2024-04-30
4:17 pm		 N/A
2034-04-28		 Verona Pharma plc VRNA Edwards Martin
Director		 240,000 $0 240,000
(Direct)		 View
2023-06-13
Option Award		 2023-06-15
4:05 pm		 N/A
2033-06-12		 Inozyme Pharma Inc. INZY Edwards Martin
Director		 16,000 $0 16,000
(Direct)		 View
2023-06-07
Option Award		 2023-06-09
4:13 pm		 N/A
2033-06-07		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 169 $73.68 8,422
(Direct)		 View
2023-06-07
Option Award		 2023-06-09
4:13 pm		 N/A
2033-06-07		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 2,137 $0 8,422
(Direct)		 View
2023-06-07
Option Award		 2023-06-09
4:13 pm		 N/A
N/A		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 1,815 $93.61 8,422
(Direct)		 View
2023-06-01
Option Award		 2023-06-05
6:59 pm		 N/A
2033-05-31		 Morphic Holding Inc. MORF Edwards Martin
Director		 12,535 $0 12,535
(Direct)		 View
2023-04-28
Option Award		 2023-04-28
4:22 pm		 N/A
2033-04-27		 Verona Pharma plc VRNA Edwards Martin
Director		 96,000 $0 96,000
(Direct)		 View
2022-06-10
Option Award		 2022-06-14
07:48 am		 N/A
2032-06-09		 Inozyme Pharma Inc. INZY Edwards Martin
Director		 9,367 $0 9,367
(Direct)		 View
2022-06-08
Option Award		 2022-06-10
7:00 pm		 N/A
2032-06-07		 Morphic Holding Inc. MORF Edwards Martin
Director		 17,550 $0 17,550
(Direct)		 View
2022-06-08
Option Award		 2022-06-09
4:20 pm		 N/A
2032-06-08		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 520 $24.02 10,441
(Direct)		 View
2022-06-08
Option Award		 2022-06-09
4:20 pm		 N/A
2032-06-08		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 5,620 $0 10,441
(Direct)		 View
2022-06-08
Option Award		 2022-06-09
4:20 pm		 N/A
N/A		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 4,242 $34.76 10,441
(Direct)		 View
2022-04-28
Option Award		 2022-04-29
4:44 pm		 N/A
2032-04-27		 Verona Pharma plc VRNA Edwards Martin
Director		 200,000 $0 200,000
(Direct)		 View
2021-06-16
Option Award(A)		 2022-04-29
4:10 pm		 N/A
2031-06-16		 Morphic Holding Inc. MORF Edwards Martin
Director		 9,996 $0 9,996
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
4:02 pm		 N/A
2032-01-03		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 99 $16.14 158
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
4:02 pm		 N/A
N/A		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 59 $27.32 158
(Direct)		 View
2021-09-30
Option Award		 2021-10-04
4:53 pm		 N/A
2031-09-29		 KalVista Pharmaceuticals Inc. KALV Edwards Martin
Director		 10,000 $0 10,000
(Direct)		 View
2021-08-09
Option Award		 2021-08-10
4:46 pm		 N/A
2031-08-08		 Verona Pharma plc VRNA Edwards Martin
Director		 64,000 $0 64,000
(Direct)		 View
2021-06-23
Option Award		 2021-06-24
4:17 pm		 N/A
2031-06-22		 Inozyme Pharma Inc. INZY Edwards Martin
Director		 9,367 $0 9,367
(Direct)		 View
2021-06-16
Option Award		 2021-06-17
7:07 pm		 N/A
2031-06-16		 Morphic Holding Inc. MORF Edwards Martin
Director		 12,000 $0 12,000
(Direct)		 View
2021-06-10
Option Award		 2021-06-14
4:11 pm		 N/A
2031-06-10		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 5,000 $0 5,000
(Direct)		 View

Ownership		 2021-01-04
8:37 pm		 N/A
N/A		 Verona Pharma plc RNA Edwards Martin
Director		 0 $0 136,776
(Direct)		 View
2020-12-01
Option Award		 2020-12-03
9:49 pm		 N/A
2030-12-01		 Morphic Holding Inc. MORF Edwards Martin
Director		 24,000 $0 24,000
(Direct)		 View

Ownership		 2020-12-03
9:47 pm		 N/A
N/A		 Morphic Holding Inc. MORF Edwards Martin
Director		 0 $0 0
(Direct)		 View
2020-10-01
Option Award		 2020-10-02
8:39 pm		 N/A
2030-09-30		 KalVista Pharmaceuticals Inc. KALV Edwards Martin
Director		 7,000 $0 7,000
(Direct)		 View
2020-08-03
Option Award		 2020-08-04
4:41 pm		 N/A
2030-08-03		 REATA PHARMACEUTICALS INC RETA Edwards Martin
Director		 16,300 $0 16,300
(Direct)		 View
2020-07-23
Option Award		 2020-07-24
4:49 pm		 N/A
2030-07-22		 Inozyme Pharma Inc. INZY Edwards Martin
Director		 9,367 $0 9,367
(Direct)		 View
(A) Indicate amendment filing.